Azenta, Inc.
NMS: AZTALive Quote
📈 ZcoreAI Score
Our AI model analyzes Azenta, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get AZTA Z-Score →About Azenta, Inc.
Healthcare
Medical Instruments & Supplies
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, gene synthesis, and related services. The company has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.
📊 Fundamental Analysis
Azenta, Inc. demonstrates a profit margin of -10.1%, which is below the sector average, suggesting competitive pressure.
The company recently reported 0.8% revenue growth, which is modest compared to its industry peers.
Return on Equity (ROE) is 1.5%, which suggests room for improvement in capital utilization.
At a current price of $22.21, AZTA currently trades near the bottom of its 52-week range (11%), indicating potential value or weakness (Range: $19.87 - $41.73).
💰 Valuation Insight
AZTA trades at a 53.2% premium to the sector average PE of 25.00. Analysts expect earnings growth, as indicated by a lower forward PE.
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
🔴
Beta (Risk)
High Volatility
Key Financials
Market Cap
$1.02B
Trailing P/E
38.29
Forward P/E
20.63
Beta (5Y)
1.47
52W High
$41.73
52W Low
$19.87
Avg Volume
917K
Day High
Day Low